Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Tian-Xiong Zhou"'
Autor:
Xiaoyun Song, Xiaofang Li, Jingyi Li, Yixin Zhang, Xiaokang Miao, Wenle Yang, Xiao-Wei Zhang, Tian-Xiong Zhou, Rui Wang, Hui Hu, Lingyun Mou, Guo-Qiang Yuan
Publikováno v:
Journal of Biological Chemistry. 292:8933-8947
Glioblastoma is the most common malignant brain tumor and has a poor prognosis. Tachykinin receptor neurokinin-1 (NK1R) is a promising target in glioblastoma therapy because of its overexpression in human glioblastoma. NK1R agonists promote glioblast
Autor:
Jingyi Li, Ming-Ning Hu, Jing-Ying Zhang, Tian-Xiong Zhou, Wenle Yang, Jing-Jie Xu, Xiaomin Guo, Xiao-Wei Zhang, Zhaoqing Xu, Junqiu Xie, Hui Hu, Lingyun Mou, Xiaokang Miao
Publikováno v:
Biochimica et Biophysica Acta (BBA) - General Subjects. 1864:129532
Background Hybridization is a useful strategy to bond the advantages of different peptides into novel constructions. We designed a series of AMPs based on the structures of a synthetic AMP KFA3 and a naturally-occurred host defense peptide substance
Autor:
Yi-Xin, Zhang, Xiao-Fang, Li, Guo-Qiang, Yuan, Hui, Hu, Xiao-Yun, Song, Jing-Yi, Li, Xiao-Kang, Miao, Tian-Xiong, Zhou, Wen-Le, Yang, Xiao-Wei, Zhang, Ling-Yun, Mou, Rui, Wang
Publikováno v:
The Journal of biological chemistry. 292(21)
Glioblastoma is the most common malignant brain tumor and has a poor prognosis. Tachykinin receptor neurokinin-1 (NK1R) is a promising target in glioblastoma therapy because of its overexpression in human glioblastoma. NK1R agonists promote glioblast
Autor:
Yi-Xin Zhang1, Xiao-Fang Li1, Guo-Qiang Yuan2, Hui Hu1, Xiao-Yun Song1, Jing-Yi Li1, Xiao-Kang Miao1, Tian-Xiong Zhou1, Wen-Le Yang1, Xiao-Wei Zhang1, Ling-Yun Mou1 muly@lzu.edu.cn, Rui Wang1 wangrui@lzu.edu.cn
Publikováno v:
Journal of Biological Chemistry. 5/26/2017, Vol. 292 Issue 21, p8933-8947. 15p.